Cargando…
Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100972/ https://www.ncbi.nlm.nih.gov/pubmed/32218598 http://dx.doi.org/10.1371/journal.pone.0230674 |
_version_ | 1783511527072989184 |
---|---|
author | Dregan, Alex McNeill, Ann Gaughran, Fiona Jones, Peter B. Bazley, Anna Cross, Sean Lillywhite, Kate Armstrong, David Smith, Shubulade Osborn, David P. J. Stewart, Robert Wykes, Til Hotopf, Matthew |
author_facet | Dregan, Alex McNeill, Ann Gaughran, Fiona Jones, Peter B. Bazley, Anna Cross, Sean Lillywhite, Kate Armstrong, David Smith, Shubulade Osborn, David P. J. Stewart, Robert Wykes, Til Hotopf, Matthew |
author_sort | Dregan, Alex |
collection | PubMed |
description | BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population. METHODS: We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014–2015. RESULTS: Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years. CONCLUSIONS: The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs. |
format | Online Article Text |
id | pubmed-7100972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-71009722020-04-03 Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom Dregan, Alex McNeill, Ann Gaughran, Fiona Jones, Peter B. Bazley, Anna Cross, Sean Lillywhite, Kate Armstrong, David Smith, Shubulade Osborn, David P. J. Stewart, Robert Wykes, Til Hotopf, Matthew PLoS One Research Article BACKGROUND: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population. METHODS: We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014–2015. RESULTS: Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years. CONCLUSIONS: The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs. Public Library of Science 2020-03-27 /pmc/articles/PMC7100972/ /pubmed/32218598 http://dx.doi.org/10.1371/journal.pone.0230674 Text en © 2020 Dregan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Dregan, Alex McNeill, Ann Gaughran, Fiona Jones, Peter B. Bazley, Anna Cross, Sean Lillywhite, Kate Armstrong, David Smith, Shubulade Osborn, David P. J. Stewart, Robert Wykes, Til Hotopf, Matthew Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title | Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title_full | Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title_fullStr | Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title_full_unstemmed | Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title_short | Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom |
title_sort | potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the united kingdom |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100972/ https://www.ncbi.nlm.nih.gov/pubmed/32218598 http://dx.doi.org/10.1371/journal.pone.0230674 |
work_keys_str_mv | AT dreganalex potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT mcneillann potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT gaughranfiona potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT jonespeterb potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT bazleyanna potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT crosssean potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT lillywhitekate potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT armstrongdavid potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT smithshubulade potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT osborndavidpj potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT stewartrobert potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT wykestil potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom AT hotopfmatthew potentialgainsinlifeexpectancyfromreducingamenablemortalityamongpeoplediagnosedwithseriousmentalillnessintheunitedkingdom |